High Systolic BP Tied to Higher Cardiovascular Mortality in T2DM

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 1, 2023 -- Clinic systolic blood pressure (BP) ≥130 mm Hg or diastolic BP levels ≥90 mm Hg are associated with a higher risk for cardiovascular disease (CVD) mortality in people with type 2 diabetes mellitus (T2DM), according to a study published online Nov. 28 in the Journal of the American Heart Association.

Loraine Liping Seng, Ph.D., from the Duke-NUS Medical School in Singapore, and colleagues investigated the association between BP and risk for CVD mortality in patients with T2DM. The analysis included 83,721 patients with T2DM (2013 to 2019).

The researchers found that among the patients, 7.6 per 1,000 person-years experienced CVD mortality. There was a graded relationship observed between systolic BP and increased CVD mortality at levels >120 to 129 mm Hg. There was a significant association between diastolic BP levels >90 mm Hg and CVD mortality in those aged 65 years and older. Diastolic BP <70 mm Hg was associated with a significantly higher risk for CVD mortality in all patients with T2DM.

"Our analysis underscores the need to control elevated systolic blood pressure to less than 130 mm Hg in patients with diabetes, while carefully evaluating risks if diastolic pressure gets too low," senior author Tazeen Jafar, also from Duke‐NUS Medical School, said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-02 00:34

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords